Silence Therapeutics raises five million pounds
Biotechnology firm Silence Therapeutics announced a five million pound placing to Henderson Global Investors and Ora Capital.
Biotechnology firm Silence Therapeutics announced a five million pound placing to Henderson Global Investors and Ora Capital.
New shares were placed at 2.5p representing a discount of around 19% to the market price.
Funds raised will be used to expand the group's research activities in short interfering RNA or ribonucleic acid and micro RNA therapies, it said.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The group specialises in RNA interference therapeutics or 'gene silencing', which can shut down or control faulty genes for the treatment of cancer and other diseases.
"The proceeds of the subscription will enhance the company's financial position and provide it with sufficient cash resources to fund the business well into 2014, even without generating any revenue," Silence said in a company statement.
The group also confirmed that shareholder Robert Keith has given written notice to convert his £1m loan note into 200,000,000 new ordinary shares at 0.5p per share bringing his stake holding to just over 26%.
Director of Corporate Strategy Ali Mortazavi said: "We are delighted to welcome Henderson as a significant shareholder in Silence. Along with further support from our existing shareholders, the company is now ideally placed to take advantage of the new wave in RNAi therapeutics."
Shares in Silence soared 12.5% to 3.60p at 13:30.
CJ
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
How does the Lifetime ISA work? Key LISA rules
What is a Lifetime ISA (LISA) and how much could the government bonus boost your savings by? We look at the perks and the pitfalls.
-
AJ Bell: a fine British fintech going cheap
Opinion Don’t overlook investment platform AJ Bell, a significantly undervalued British business with an excellent financial base